Genscript Biotech Corporation

HKEX:1548.HK

12.1 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income -175.115-1.896-93.581-91.344-135.507-267.59-91.122-91.853-113.092-69.566-27.3465.69715.51911.14314.9812.97913.19111.7585.7462.1294.0461.544
Depreciation & Amortization 40.29538.52435.52231.16330.0222.85823.00618.27914.05211.2339.1276.6535.6813.5883.0272.5472.4952.2162.4692.3422.3611.225
Deferred Income Tax 00-8.995-17.583-60.72832.784-58.90977.848-10.61132.53-20.8537.636-222.895232.1383.871-1.5873.4931.4620.7910.284-0.0310
Stock Based Compensation 53.34921.73238.85928.70336.45125.18114.5110.1757.4625.2325.555.2813.5711.8190.9921.0520.7841.9231.4252.0981.1860.821
Change In Working Capital 93.179-94.5-56.15296.39235.7470.67160.367-50.946-2.44179.854-127.559-125.514328.65-221.636-11.2961.009-2.214-8.632-0.3231.435-1.808-0.043
Accounts Receivables 83.288-86.376-30.612-0.40538.471-46.31547.884-77.2387.329-31.94917.908-8.873220.682-232.437-3.4380.959-3.478-3.149-1.857-2.256-0.9080
Change In Inventory -4.917-4.6760.748-5.331-14.194-11.65-3.485-10.785-4.18-5.813-2.605-4.044-1.358-1.52-1.425-0.424-0.799-0.236-0.359-0.126-0.247-0.093
Change In Accounts Payables 00000000000000000002.303-0.0510
Other Working Capital 14.808-3.448-26.288102.12811.463128.63615.96837.077-5.589217.616-142.862-112.597109.32612.321-6.4330.4742.063-5.2471.8933.817-0.6530.051
Other Non Cash Items 68.147-63.603-111.816-123.209-28.70147.944-42.61532.38724.883-3.406-13.07459.5182.603218.1070.6440.9240.5083.097-0.043-1.620.037-0.496
Operating Cash Flow 79.855-99.743-187.168-58.295-61.997-100.936-35.854-81.958-69.135123.347-153.302-48.365356.02413.0218.34718.51114.76410.3629.2746.3845.8223.052
Investing Activities:
Investments In Property Plant And Equipment -134.026-172.249-80.197-142.188-73.925-64.287-68.757-63.738-58.141-56.533-53.838-15.868-54.971-16.268-12.947-4.413-4.14-2.964-3.747-3.243-4.112-1.879
Acquisitions Net 00000000000-2.141-25.4540.901-0.90100.07100-0.681-0.4880
Purchases Of Investments 0000000000000000000-1.022-7.612-7.612
Sales Maturities Of Investments 00000000000000000001.7038.18.1
Other Investing Activites -999.028269.064-374.34635.764-262.94720.657-100.16175.444-53.731-91.963-6.299-73.685-21.843-3.833-3.403-0.3510.518-0.0142.626-2.7150.9561.391
Investing Cash Flow -1,133.05496.815-454.543-106.424-336.872-43.63-168.91811.706-111.872-148.496-60.137-91.694-102.268-19.2-17.251-4.764-3.551-2.978-1.121-5.958-3.156-2.279
Financing Activities:
Debt Repayment -22.2660-2.4030-3.460-27.8140-30.3270-8.0590-0.6050000000-3.786-3.786
Common Stock Issued 000000000000000000019.04700
Common Stock Repurchased 00000000-9.46-5.503-2.271-11.4750000000000
Dividends Paid 0000000000000-0.002-2.6330000000
Other Financing Activities 27.83148.2411,022.422411.0894.768369.155560.8-12.057615.3930.244-3.30713.594254.5982.9941.68-0.2058.69273.346-8.1780.61-0.2153.786
Financing Cash Flow 5.56548.2411,020.019411.0898.228369.155532.986-12.057636.26-5.2592.4812.119255.2032.992-0.953-0.2058.69273.346-8.1780.61-0.215-1.743
Other Information:
Effect Of Forex Changes On Cash 0.5283.756-4.973-4.617-8.084-1.2330.3434.674-0.957-0.774-0.021-0.109-0.209-3.7054.1420.855-1.558-2.6940.0720.138-0.4451.765
Net Change In Cash -1,047.10649.069373.335241.753-398.725223.356328.557-77.635454.296-31.182-210.979-138.049508.75-6.892-5.71514.39718.34778.0360.0471.46718.8490.795
Cash At End Of Period 399.2971,446.4031,397.3341,023.999782.2461,180.971957.615629.058706.693252.397283.579494.558632.607123.857130.749136.464122.067103.7225.68425.9324.4636.409